Does JATR follow COPE flowcharts for misconduct?
Yes. All cases of suspected ethical misconduct are managed in strict accordance with COPE flowcharts and documentation protocols.
Promoting integrity, accountability and ethical conduct in addiction science publishing.
JATR adheres to internationally recognized ethical standards for scholarly publishing as defined by the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME). Every manuscript is handled transparently and responsibly to ensure reliability of the academic record.
Core Principle: Ethical publishing is a shared duty among authors, reviewers, editors and the publisher—each ensuring accuracy, honesty and fairness in reporting research.
Ghostwriting, honorary authorship or duplicate submissions constitute unethical behavior and are grounds for rejection or retraction.
Editors are responsible for evaluating manuscripts solely on their academic merit and relevance, free from discrimination or external influence. Editorial decisions are guided by:
Reviewers are recognized as vital contributors to JATR’s quality assurance process.
Heighten Science Publications Inc. ensures editorial freedom, transparency in pricing and strict adherence to ethical norms. The publisher:
Authors must confirm that their research complies with the Declaration of Helsinki (2013 revision) for human subjects and the ARRIVE or U.K. Animals (Scientific Procedures) Act 1986 for animal research. Studies involving human participants require informed consent and explicit ethics-committee approval numbers.
Editors may request documentation of ethical approvals or participant consent forms before acceptance.
When misconduct such as plagiarism, fabrication, falsification or data manipulation is alleged, the editorial office follows COPE Flowcharts for transparent investigation. Corrective actions may include:
All outcomes are documented and shared publicly to maintain accountability.
All participants in the publication process must disclose any conflicts that could bias judgment or interpretation. Conflicts include employment, consultancies, stock ownership, honoraria, or institutional affiliations. Disclosure statements appear in published articles under “Conflict of Interest.”
Post-publication issues are managed according to COPE and Crossref retraction guidelines:
Retracted articles remain available with watermarks and explanatory notices.
Authors are encouraged to deposit datasets, protocols and analysis codes in recognized repositories (e.g., Figshare, Zenodo) and cite them using DOIs. Transparent reporting strengthens reproducibility in addiction research.
JATR promotes awareness of publication ethics by offering webinars, reviewer workshops and author resources. All editorial board members undergo annual COPE-compliance refreshers.
Yes. All cases of suspected ethical misconduct are managed in strict accordance with COPE flowcharts and documentation protocols.
Each correction or retraction includes a dated statement detailing reasons and approval by the Editor-in-Chief.
Yes. Readers can email [email protected] with supporting evidence. All reports are handled confidentially.